Yi-Ting Gong1, Li-Jun Zhang2, Yi-Chen Liu2

  • 1Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China.

Pharmacological research
|November 16, 2023
PubMed
概括

中性粒细胞是乳腺癌 (BC) 进展的关键参与者,作为抗瘤 (N1) 或前瘤 (N2) 细胞. 向中性粒细胞提供了新的BC疗法的潜力,尽管目前面临挑战.